

Struggling to find Carbidopa/Levodopa at your pharmacy? Learn why this essential Parkinson's medication is hard to find in 2026 and what you can do.
You call your pharmacy. They tell you Carbidopa/Levodopa is out of stock. You try another pharmacy — same story. If this sounds familiar, you're one of thousands of patients dealing with this frustrating reality in 2026.
Carbidopa/Levodopa is one of the most important medications for Parkinson's disease. It's been around for decades and is considered the gold standard treatment. So why is it so difficult to find?
In this article, we'll explain what Carbidopa/Levodopa is, why it's hard to find right now, and — most importantly — what you can do about it.
Carbidopa/Levodopa is a combination medication used to treat the symptoms of Parkinson's disease, including tremors, stiffness, and difficulty moving. It works by increasing dopamine levels in the brain — a chemical that's depleted in people with Parkinson's.
Levodopa is converted to dopamine in the brain, while Carbidopa prevents Levodopa from breaking down before it gets there. Together, they're more effective and cause fewer side effects than Levodopa alone.
You may know this medication by its brand names: Sinemet, Sinemet CR, Rytary, Crexont, or Duopa. The generic version is widely available — or at least it should be. For a deeper look at what this drug does, check out our guide on what Carbidopa/Levodopa is and how it's used.
There are several reasons you might be struggling to fill your prescription. Here's what's going on:
Some manufacturers have stopped making certain formulations of Carbidopa/Levodopa. For example, Accord discontinued the 25/100 mg extended-release tablet, and Sun Pharma stopped producing the 25/250 mg orally disintegrating tablet (ODT). When a manufacturer exits the market, the remaining companies can't always ramp up production fast enough to cover the gap.
Pharmaceutical supply chains are complex and global. Raw ingredient shortages, shipping delays, and quality control issues at manufacturing plants can all contribute to reduced availability. Because Carbidopa/Levodopa is a relatively low-cost generic, profit margins are thin, which gives manufacturers less incentive to invest in expanding production.
As the population ages, more people are being diagnosed with Parkinson's disease. The Parkinson's Foundation estimates that nearly one million Americans are living with PD, and that number is expected to rise. More patients means more prescriptions — and more pressure on an already strained supply.
Not all forms of Carbidopa/Levodopa are equally affected. Immediate-release (IR) tablets are generally easier to find, while extended-release (ER/CR) tablets and orally disintegrating tablets (ODT) have experienced the worst shortages. If your doctor prescribed a specific formulation, you may have a harder time than someone on the standard IR tablet.
For the latest on the shortage situation, see our Carbidopa/Levodopa shortage update for 2026.
The good news is you have options. Here's what you can do if you can't find Carbidopa/Levodopa:
Instead of calling pharmacy after pharmacy, use Medfinder to search for pharmacies near you that have Carbidopa/Levodopa in stock. It saves time and takes the guesswork out of finding your medication. You can also read our detailed guide on how to check if a pharmacy has Carbidopa/Levodopa in stock.
Big chain pharmacies often sell out quickly because they serve more customers. Independent pharmacies sometimes have better stock of medications in shortage. Don't overlook them — they can also provide more personalized service. Check out our tips on how to find Carbidopa/Levodopa in stock near you.
If your specific formulation is unavailable, your doctor may be able to switch you to a different strength or form. For example, if the extended-release version is out of stock, you might be able to take immediate-release tablets more frequently throughout the day. In some cases, your doctor might consider alternative medications like Pramipexole (Mirapex) or Ropinirole (Requip).
Many pharmacies can order Carbidopa/Levodopa from their distributor if it's available. Ask your pharmacist to place a special order. It may take a day or two, but this often works when the shelf is empty.
This is critical. Suddenly stopping Carbidopa/Levodopa can cause a dangerous reaction similar to neuroleptic malignant syndrome, with symptoms like high fever, muscle rigidity, and confusion. If you're running low, talk to your doctor right away — don't wait until you've completely run out.
Finding Carbidopa/Levodopa shouldn't be this hard, but until supply catches up with demand, patients need to be proactive. Use tools like Medfinder, build a relationship with your pharmacist, and keep your doctor in the loop about any supply issues you're experiencing.
You deserve consistent access to the medication that keeps your Parkinson's symptoms under control. And with the right strategy, you can find it.
Looking to save money on your prescription? Read our guide on how to save money on Carbidopa/Levodopa in 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.